Regan M. Memmott, Li Zheng, Guillermo Streich, Karina Vera, Juan Cundom, Daniel Brungs, Thomas John, Geoffrey Liu, Mengzhao Wang, Yun Fan, Dongqing Lv, Meili Sun, Dingzhi Huang, Qunying Hong, Xingya Li, Ying Hu, Jian Fang, Yanqiu Zhao, Kejing Tang, Xia Song, Junqiang Zhang, Yu Yao, Zili Meng, Chengzhi Zhou, Zhangzhou Huang, Huashan Shi, Junzhen Gao, Jianhua Shi, Aiping Zeng, Bin Yang, Anwen Liu, Bo Jin, Yan Yu, Ying Cheng, Jianying Zhou, Lin Wu, Ludovic Doucet, Laurent Greillier, David Planchard, Julien Mazières, François Ghiringhelli, Gérard Zalcman, Michaël Duruisseaux, Nicolas Isambert, Alexis Cortot, Alessandra Bearz, Marcello Tiseo, Vincenzo Di Noia, Hector Soto Parra, Manolo D'Arcangelo, Lorenzo Antonuzzo, Chun SenLim, Yong Kek Pang, Ki Hyeong Lee, Tae Min Kim, Yu Jung Kim, Byoung-Yong Shim, Dae Ho Lee, Ji-Youn Han, Enriqueta Felip, Manuel Angel Cobo Dols, Luis Paz-Ares Rodríguez, Joaquim Bosch-Barrera, Enric Carcereny, Javier de Castro Carpeño, Jesus Corral Jaime, Andres Barba Joaquin, Gonzalo Fernandez Hinojal, Pilar Garrido Lopez, David Vicente Baz, Manuel Domine Gomez, Maria-Jose de Miguel-Luken, James Chih-Hsin Yang, Yung-Hung Luo, Tsung-Ying Yang, Ping-Chih Hsu, Chien-Chung Lin, Pasi A. Jänne, Lyudmila Bazhenova, Bruna Pellini, Regan Michelle Memmott, Elaine Shum, Xiuning Le. "Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non–Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (WU-KONG1B)." Journal of Clinical Oncology, 2025. doi:10.1200/jco-25-00788